Invega and Dilantin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invega and Dilantin. Common interactions include hepatocellular damage among females and arrhythmia among males.

The phase IV clinical study analyzes what interactions people who take Invega and Dilantin have. It is created by eHealthMe based on reports of 13 people who take Invega and Dilantin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

13 people who take Invega and Dilantin together, and have interactions are studied.

What is Invega?

Invega has active ingredients of paliperidone. It is often used in bipolar disorder. eHealthMe is studying from 30,825 Invega users for its effectiveness, alternative drugs and more.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,839 Dilantin users for its effectiveness, alternative drugs and more.

Number of Invega and Dilantin reports submitted per year:

Common Invega and Dilantin drug interactions by gender *:

female:

Hepatocellular damage
Hypospadias
Muscle spasms
Oedema peripheral
Pancreatitis
Renal injury
Suicide attempt
Galactorrhoea
Hyperprolactinaemia
Headache

male:

Arrhythmia
Death

Common Invega and Dilantin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death

50-59:

Breast swelling
Oedema peripheral

60+:

Muscle spasms

Common conditions people have *:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 38.46%
Stress And Anxiety: 3 people, 23.08%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 23.08%
Borderline Personality Disorder: 3 people, 23.08%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 15.38%
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 2 people, 15.38%
Migraine (headache): 2 people, 15.38%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 7.69%
Psychotic Disorder: 1 person, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Invega and Dilantin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .